These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 12379585

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by I(K)-blocking drugs.
    Pham TV, Sosunov EA, Gainullin RZ, Danilo P, Rosen MR.
    Circulation; 2001 May 01; 103(17):2207-12. PubMed ID: 11331264
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve.
    Biliczki P, Virág L, Iost N, Papp JG, Varró A.
    Br J Pharmacol; 2002 Oct 01; 137(3):361-8. PubMed ID: 12237256
    [Abstract] [Full Text] [Related]

  • 5. Effects of gonadal steroids on ventricular repolarization and on the response to E4031.
    Hara M, Danilo P, Rosen MR.
    J Pharmacol Exp Ther; 1998 Jun 01; 285(3):1068-72. PubMed ID: 9618409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G, Xue X, Gao C, Huang J, Qi D, Zhang Y, Dong JZ, Ma CS, Yan GX.
    J Am Heart Assoc; 2017 May 18; 6(5):. PubMed ID: 28522677
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo.
    Carlsson L, Andersson B, Linhardt G, Löfberg L.
    J Cardiovasc Pharmacol; 2009 Jul 18; 54(1):82-9. PubMed ID: 19528812
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the rate dependent effects of dofetilide and ibutilide in the newborn heart.
    Pickoff AS, Stolfi A.
    Pacing Clin Electrophysiol; 2001 May 18; 24(5):816-23. PubMed ID: 11388101
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dispersion of ventricular repolarization and ventricular fibrillation in left ventricular hypertrophy: influence of selective potassium channel blockers.
    Gillis AM, Mathison HJ, Kulisz E, Lester WM.
    J Pharmacol Exp Ther; 2000 Jan 18; 292(1):381-6. PubMed ID: 10604974
    [Abstract] [Full Text] [Related]

  • 17. Blockade of IKs by HMR 1556 increases the reverse rate-dependence of refractoriness prolongation by dofetilide in isolated rabbit ventricles.
    So PP, Hu XD, Backx PH, Puglisi JL, Dorian P.
    Br J Pharmacol; 2006 Jun 18; 148(3):255-63. PubMed ID: 16565733
    [Abstract] [Full Text] [Related]

  • 18. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents.
    Orth PM, Hesketh JC, Mak CK, Yang Y, Lin S, Beatch GN, Ezrin AM, Fedida D.
    Cardiovasc Res; 2006 Jun 01; 70(3):486-96. PubMed ID: 16545351
    [Abstract] [Full Text] [Related]

  • 19. Electrophysiological effects of dofetilide in an in vitro model of "border zone" between normal and ischemic/reperfused myocardium.
    Rouet R, Picard S, Libersa C, Ghadanfar M, Alabaster C, Gérard JL.
    Circulation; 2006 Jun 01; 101(1):86-93. PubMed ID: 10618309
    [Abstract] [Full Text] [Related]

  • 20. Class III effects of dofetilide and arrhythmias are modulated by [K+]o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
    Ducroq J, Rouet R, Sallé L, Puddu PE, Repessé Y, Ghadanfar M, Ducouret P, Gérard JL.
    Eur J Pharmacol; 2006 Feb 27; 532(3):279-89. PubMed ID: 16480976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.